Atea Pharmaceuticals Appoints Arthur Kirsch as Class I Director Amid Voting Agreement Disclosure
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) announced on February 20, 2025, that its Board of Directors has elected Arthur Kirsch as a Class I director, effective immediately. The company’s board recognized Mr. Kirsch’s extensive background in healthcare investment banking and strategic advisory roles as a valuable addition to its leadership team. Mr. Kirsch, 73, has been […]
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) announced on February 20, 2025, that its Board of Directors has elected Arthur Kirsch as a Class I director, effective immediately. The company’s board recognized Mr. Kirsch’s extensive background in healthcare investment banking and strategic advisory roles as a valuable addition to its leadership team. Mr. Kirsch, 73, has been […]
